SEARCH

SEARCH BY CITATION

References

  • 1
    Handszuh H, Waters S. In: DuPontH, SteffenR eds.. Travel tourism patterns. Textbook of travel medicine and health 1997 Hamilton : BC Decker; 2026.
  • 2
    WTO. Tourism market trends, world, 1985–1996. Hamilton : WTO 1997.
  • 3
    Monden M, Meester W. Mental decompensation during travel abroad. Ned Tijdschr Geneeskd 1994; 23: 15201523.
  • 4
    Sauteraud A, Hajjar M. Psychotic disorders: higher incidence during travel to Asia. Press-Med 1992; 21: 805810.
  • 5
    Rishpon S. Update on malaria prophylaxis among travelers. Press-Med 1992; 21: 805810.
  • 6
    Anonymous. Diagnostic and statistical manual of mental disorders, Washington , DC American Psychiatric Association, 1994.
  • 7
    Anonymous. Statistical Package for Social Sciences, Chicago : SPSS, Inc. 1997.
  • 8
    Young D. Psychiatric morbidity in travelers to Honolulu, Hawaii. Compr Psychiatry 1995; 36: 224228. 7648847
  • 9
    Hirshon J, Eng T, Brunkow K, Hartzell N. Psychological and readjustment problems associated with emergency evacuation of peace corps volunteers. J Travel Med 1997; 4: 128131. 9815497
  • 10
    Struchler D, Handschin J, Kaiser D, Kerr L, Mittelholzer M, Reber R. Neuropsychiatric side effects of mefloquine. N Engl J Med 1991; 322: 17521753.
  • 11
    Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K. Neuropsychiatric side effects after use of mefloquine. Am J Trop Med Hyg 1991; 45: 8691. 1867351
  • 12
    Phillips-Howard P, Kuile F. CNS adverse events associated with antimalarial agents. Drug Saf 1995; 12: 370383. 8527012
  • 13
    Croft A, World M. Neuropsychiatric reactions with mefloquine chemoprophylaxis. Lancet 1996; 347: 347347. 8598699
  • 14
    Sowunmi A, Adio R, Odula A. 14. Sowunmi A, Adio R, Odula A. Acute psychosis after mefloquine. Report of six cases. Trop Geogr Med 1995; 47: 179180. 8560592
  • 15
    Levav I, Kohn R, Dohrenwend B et al. An epidemiological study of mental disorders in a 10-year cohort of young adults in Israel. Psychol Med 1993; 23: 691707. 8234576
  • 16
    Dawson-Saunders B, Trapp R. Basic and clinical biostatistics 1994 East Norwalk CT : Appleton Lange.
  • 17
    Phillips M, Kass R. User acceptability patterns of mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med 1996; 3: 1015.
  • 18
    Huzley D. Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions. J Travel Med 1996; 3: 148155. 9815443
  • 19
    Barrett P, Emmins P, Clarke P, Bradley D. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travelers. BMJ 1996; 313: 525528. 8789977
  • 20
    Wittes R, Sagnur R. Adverse reaction to mefloquine associated with ethanol ingestion. CMAJ 1995; 152: 515517. 7859199
  • 21
    Anonymous. ReynoldsJ. Mefloquine hydrochloride. Martindale, the extra pharmacopea. 1996 London Royal Pharmaceutical Society; 468470.
  • 22
    Palmer K, Holiday S, Brogden R. Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993; 45: 430475. 7682911
  • 23
    Patchen LC, Campbell CC, Williams SB. Neurologic reactions after a dose of mefloquine. N Engl J Med 1989; 321: 14151416. 2811953
  • 24
    Karbwang J, White N. Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 1990; 19: 264279. 2208897
  • 25
    Derogatis L, Rickels K, Rock A. The SCL-90 and MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976; 128: 280289. 1252693